Beyond Vision: How Oculomics and AI Are Redefining the Future of Preventive Healthcare
The human eye has long been regarded as a window to vision, but advances in retinal imaging, artificial intelligence (AI), and the emerging field of oculomics are revealing its far greater potential. Today, a simple, non-invasive retinal scan can provide valuable insights into an individual’s overall health, enabling the early detection of chronic conditions such as diabetes, cardiovascular disease, kidney disorders, and even neurodegenerative diseases. As healthcare shifts from reactive treatment to predictive and preventive care, retinal imaging is emerging as a powerful tool for population-scale screening and personalized health management.
In this interaction, Dr. Roshan Christina Clinical Consultant – AI in Ophthalmology & Oculomics at Forus Health Pvt Ltd, shares her insights on how AI-powered retinal diagnostics and ocular imaging are transforming modern healthcare. She discusses the growing role of oculomics, the latest advancements in retinal imaging, and how these innovations can help make preventive healthcare more accessible, scalable, and effective while addressing India’s rising burden of chronic diseases.
1. What role is retinal imaging playing in the early detection of systemic diseases?
The advances in imaging technology and artificial intelligence (AI) are transforming retinal scans into powerful indicators of overall health. Retinal images contain far more predictive information than was previously appreciated. Retinal blood vessels are part of the body’s microvascular network, they often show signs of disease earlier than larger blood vessels elsewhere. Owing to the smaller dimensions of these vessels they naturally tend to get affected sooner. Changes in their tissue can be picked up early which reasonably reflects the health of blood vessels throughout the rest of the body. Changes in vessel caliber, branching patterns, tortuosity and microvascular integrity have been associated with hypertension, diabetes, cardiovascular disease, stroke risk and chronic kidney disease. Unlike blood vessels in many other organs that require invasive procedures, retinal blood vessels can be visualized through retinal imaging which is rapid and non-invasive. In other words, a painless eye scan that only takes few minutes and can be repeated frequently.
2. Oculomics is gaining global attention. How do you see this field evolving over the next five years?
Traditionally, retinal imaging relied on fundus photography and clinical interpretation to document ophthalmic diseases. Today, however, the emergence of Oculomics is transforming retinal imaging from a largely ‘qualitative’ discipline into a data-rich, ‘quantitative’ science. Advanced imaging systems can now capture biomarkers that were previously invisible to the human eye; including vessel caliber and tortuosity, retinal layer thickness, microvascular density and subtle structural changes that may signal systemic disease. Organizations such as Forus Health are helping accelerate this shift through a combination of advanced retinal imaging devices, AI-powered analytics and connected telehealth platforms. By enabling the capture, analysis and interpretation of retinal data at scale, these technologies are laying the foundation for more accessible, predictive and preventive healthcare.
I often summarize the future of retinal screening through the lens of five Ps: Portable, Primary Care, Predictive, Pre-screening and Personalized. Retinal screening will become increasingly portable and accessible, integrating seamlessly into routine primary care while serving as a predictive pre-screening tool that helps create personalized health roadmaps and treatment plans.
In the next 5–10 years, a retinal scan may become the modern stethoscope of preventive medicine capable of revealing not only the health of the eye but also the future health of the heart, brain, kidneys and beyond. The retina will evolve from a “window to the eye” into a “dashboard for human health”.
3. Can retinal scans become a routine screening tool for detecting chronic diseases beyond eye disorders?
With the pace at which technology is advancing, I can see a shift in the approach of healthcare professionals, irrespective of their field of expertise with the majority adopting retinal imaging as part of their regular practice. Traditional retinal examination focuses on features clinicians can see. But now, AI can analyze millions of pixels simultaneously, complex vascular geometries, textural patterns and subtle relationships invisible to human observers. As a result, retinal images contain far more predictive information than was previously appreciated. Along with the knowledge drawn from years of clinical experience, healthcare professionals can now use the assistance of AI to better predict, diagnose, treat and optimize their overall patient care.
4. What are the biggest advancements in ocular imaging that are reshaping modern healthcare?
I can’t emphasize enough “The Rise of OCT”. The widespread adoption of Optical Coherence Tomography (OCT) has revolutionized Ophthalmology by enabling near-histological visualization of retinal layers in vivo. Advances such as OCT Angiography (OCTA) has made it possible to visualize retinal blood flow and capillary networks without dye injections, revealing microvascular changes earlier than ever before.
Apart from leveraging advances in ocular imaging for the diseases previously mentioned, research is increasingly showing that the eye can be a powerful, non-invasive window into neurodegenerative disease as well. As the retina is an extension of the central nervous system, subtle retinal changes can reflect pathological processes occurring in the brain long before clinical symptoms emerge. Again, OCT and OCTA have revealed structural changes in nerve fibre layer and microvascular alterations associated with conditions like Alzheimer’s Disease, Parkinson’s Disease and Multiple Sclerosis. Emerging modalities, including hyperspectral imaging and adaptive optics, offer the potential to detect molecular and cellular changes, such as retinal amyloid deposition, at unprecedented resolution.
Complementing these innovations, artificial intelligence is enabling the identification of complex retinal biomarkers that may predict cognitive decline, neurodegenerative risk and even biological brain age from routine retinal images. Apart for cardiovascular conditions, a simple retinal scan could help identify risk of neurodegenerative disorders years before symptoms arise, enabling earlier intervention, personalized care and improved outcomes. The retina may ultimately become one of the most accessible and informative biomarkers of brain health.
5. How can AI-powered retinal diagnostics help address India’s growing burden of diabetes and cardiovascular diseases?
Traditional screening approaches typically evaluate one disease, one organ or one biomarker at a time. In contrast, advances in retinal imaging, combined with artificial intelligence, are transforming the eye into a powerful gateway for understanding overall health. A single, non-invasive retinal scan can now provide insights across multiple disease areas, enabling earlier detection, broader risk assessment and more scalable preventive care. When coupled with telecare platforms that facilitate seamless screening workflows, these capabilities can be extended even to remote and underserved communities, making quality healthcare more accessible than ever before.
AI-powered retinal diagnostics in diabetes has enabled rapid, accurate and scalable detection of retinal changes from fundus photographs and OCT scans. AI algorithms can identify the earliest signs of Diabetic Retinopathy, facilitating timely referral and treatment before vision loss occurs. Beyond screening, AI is increasingly being used to assess disease severity, predict progression and monitor response to therapy. Recent advances in Oculomics suggest that retinal images may also reveal insights into systemic diabetic complications, including cardiovascular disease, kidney dysfunction & metabolic control. With evolving algorithms and multimodal imaging, AI-powered retinal diagnostics are poised to become a cornerstone of diabetes management, transforming the retina from a target organ of diabetic damage into a valuable biomarker for overall systemic health.
The potential applications are vast and continue to expand. In the near future, a retinal health report may simultaneously assess eye health, estimate biological age, evaluate the risk of cardiovascular disease, stroke, kidney disease, neurodegenerative disorders and recommend appropriate follow-up investigations. Rather than simply identifying existing disease, it could provide an individualized health forecast that supports the broader vision of precision medicine.
For clinicians, this offers a more holistic view of patient health. For individuals, it provides actionable insights that can drive timely interventions and healthier outcomes. Viewed through this lens, retinal evaluation has the potential to become a routine component of whole-body health assessment, shifting healthcare from reactive treatment to proactive risk management, reducing the burden of disease detection and management on the system tremendously.
